Regulus Btn
Stanley T. Crooke, M.D., Ph.D.
Chairman and Chief Executive Officer


Welcome to the Isis Pharmaceuticals management communications page. Here you will find correspondence from Isis' executive management regarding the latest company developments and insight on the broad opportunity of RNA-based drug discovery.

Chairman's Quarterly Review: